Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Is a Beat in Store for CRISPR (CRSP) This Earnings Season?
09:01am, Friday, 23'rd Apr 2021
On CRISPR Therapeutics' (CRSP) first-quarter earnings call, investor focus will be on updates of the company's progress with the development of its lead gene-editing candidate, CTX001.
2 Unstoppable Cathie Wood Stocks That Could Make You Rich
06:35am, Friday, 23'rd Apr 2021
Both of these stocks have struggled in recent weeks, which means it might be a good time to initiate a position.
Crispr Therapeutics: Pipeline Catalyst Triggering Upside
11:20pm, Thursday, 22'nd Apr 2021
Crispr Therapeutics: Pipeline Catalyst Triggering Upside
Vertex Pharmaceuticals Raises Bet on CRISPR Therapeutics
04:29pm, Tuesday, 20'th Apr 2021
The amended collaboration agreement comes with a big up-front payment.
Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for
01:32pm, Tuesday, 20'th Apr 2021
CRISPR Therapeutics AG (CRSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Crispr, KalVista And Syndax Are Moving Today
09:18am, Tuesday, 20'th Apr 2021
CRISPR Therapeutics AG (NASDAQ: CRSP), Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) and KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) were among the early movers in the biopharma space Tuesday. CRISPR
- Under terms of amended agreement, Vertex to lead worldwide development, manufacturing and commercialization of CTX001-
CRISPR Therapeutics: A Speculative Play On The Future Of Medicine
03:39pm, Monday, 19'th Apr 2021
CRISPR Therapeutics stock reached a 52-week high of $220.20 in Jan 2021 and has since fallen significantly down to $114.39 as of Apr 12, 2021.
CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today
03:51pm, Friday, 16'th Apr 2021
A "sell" rating is one thing, but a price target barely half of the Thursday close? It's no wonder Editas stock is crashing, and taking other gene-editing stocks with it.
CRISPR Therapeutics AG (CRSP) Presents at 20th Annual Needham Virtual Healthcare Conference (Transcript)
01:14pm, Monday, 12'th Apr 2021
CRISPR Therapeutics AG (CRSP) Presents at 20th Annual Needham Virtual Healthcare Conference (Transcript)
ZUG, Switzerland and CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for se
ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance
07:27am, Friday, 02'nd Apr 2021
ARK Genomic Revolution Multi-Sector ETF: Poised For Continued Underperformance
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
06:56pm, Thursday, 25'th Mar 2021
CRISPR Therapeutics AG (CRSP) closed at $114.60 in the latest trading session, marking a -0.82% move from the prior day.
2 Cathie Wood Stocks That Are 40% Off
06:43am, Sunday, 21'st Mar 2021
These companies may represent the future, but their stocks are getting pummeled in the present.
CRISPR Therapeutics AG (CRSP) Down 12.6% Since Last Earnings Report: Can It Rebound?
12:30pm, Thursday, 18'th Mar 2021
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock?
